Stockholders’ Equity (Tables)
|
3 Months Ended |
Mar. 31, 2023 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the
three months ended March 31, 2023 and 2022:
Schedule of Share Based Payments Award Stock
Options Valuation Assumptions
| |
|
2023 |
|
|
2022 |
|
| Dividend yield |
|
|
0.0 |
% |
|
|
0.00 |
% |
| Risk-free interest rate |
|
|
4.05 |
% |
|
|
0.95-1.65 |
% |
| Expected volatility |
|
|
100.2 |
% |
|
|
106.4-110.0 |
% |
| Expected life (in years) |
|
|
5 |
|
|
|
5 |
|
|
| Schedule of Stock Option Activity |
Option
activity for the three months ended March 31, 2023 and the year ended December 31, 2022 was as follows:
Schedule
of Share Based Compensation Stock Option Activity
| |
|
Options |
|
|
Weighted
Average
Exercise
Price ($) |
|
|
Weighted
Average
Remaining
Contractual
Life (Yrs.) |
|
|
Aggregate
Intrinsic
Value ($) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding at December 31, 2021 |
|
|
1,395,882 |
|
|
|
4.24 |
|
|
|
3.89 |
|
|
|
-
|
|
| Granted |
|
|
487,473 |
|
|
|
2.50 |
|
|
|
4.43 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(84,302 |
) |
|
|
4.39 |
|
|
|
- |
|
|
|
- |
|
| Options outstanding at December 31, 2022 |
|
|
1,799,053 |
|
|
|
3.76 |
|
|
|
3.30 |
|
|
|
- |
|
| Granted |
|
|
433,665 |
|
|
|
0.58 |
|
|
|
4.83 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(170,059 |
) |
|
|
3.04 |
|
|
|
- |
|
|
|
- |
|
| Options outstanding March 31, 2023 |
|
|
2,062,659 |
|
|
|
3.15 |
|
|
|
3.41 |
|
|
|
- |
|
| Options expected to vest in the future as of March 31, 2023 |
|
|
555,378 |
|
|
|
1.99 |
|
|
|
4.16 |
|
|
|
- |
|
| Options exercisable at March 31, 2023 |
|
|
1,507,281 |
|
|
|
3.58 |
|
|
|
3.14 |
|
|
|
- |
|
| Options vested, exercisable, and options expected to vest at March 31, 2023 |
|
|
2,062,659 |
|
|
|
3.15 |
|
|
|
3.41 |
|
|
|
- |
|
|
| Schedule of Warranty Activity |
Warrant
activity for the three months ended March 31, 2023 and the year ended December 31, 2022 was as follows:
Schedule
of Warranty Activity
| |
|
Warrants |
|
|
Weighted
Average
Exercise
Price ($) |
|
|
Weighted
Average
Remaining
Contractual
Life (Yrs.) |
|
| Warrants outstanding at December 31, 2021 |
|
|
3,987,931 |
|
|
|
6.10 |
|
|
|
2.10 |
|
| Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(164,652 |
) |
|
|
- |
|
|
|
- |
|
| Warrants outstanding at December 31, 2022 |
|
|
3,823,279 |
|
|
|
4.66 |
|
|
|
1.19 |
|
| Granted |
|
|
1,490,896 |
|
|
|
0.58 |
|
|
|
2.87 |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Warrants outstanding at March 31, 2023 |
|
|
5,314,175 |
|
|
|
3.19 |
|
|
|
1.48 |
|
|
| Stock Appreciation Rights [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of SAR awards was estimated using the Black-Scholes model with the following weighted average assumptions for the three
months ended March 31, 2023 and March 31, 2022:
Schedule
of Share Based Payments Award Stock Options Valuation Assumptions
| |
|
2023 |
|
|
2022 |
|
| Dividend yield |
|
|
- |
|
|
|
0.00 |
% |
| Risk-free interest rate |
|
|
- |
|
|
|
0.82-1.65 |
% |
| Expected volatility |
|
|
- |
|
|
|
108.4-119.0 |
% |
| Expected life (in years) |
|
|
- |
|
|
|
5 |
|
|
| Schedule of Stock Option Activity |
SARs
activity for the three months ended March 31, 2023 and the year ended December 31, 2022 was as follows:
Schedule
of Stock Option Activity
| |
|
Options |
|
|
Weighted
Average
Exercise
Price ($) |
|
|
Weighted
Average
Remaining
Contractual
Life (Yrs.) |
|
|
Aggregate
Intrinsic
Value ($) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| SARs outstanding at December 31, 2021 |
|
|
370,624 |
|
|
|
3.15 |
|
|
|
4.24 |
|
|
|
- |
|
| Granted |
|
|
814,862 |
|
|
|
1.81 |
|
|
|
4.48 |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(27,699 |
) |
|
|
2.91 |
|
|
|
- |
|
|
|
- |
|
| SARs outstanding at December 31, 2022 |
|
|
1,157,787 |
|
|
|
2.21 |
|
|
|
4.11 |
|
|
|
-
|
|
| Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Forfeited or cancelled |
|
|
(166,156 |
) |
|
|
20.9 |
|
|
|
- |
|
|
|
- |
|
| SARs outstanding March 31, 2023 |
|
|
991,631 |
|
|
|
2.23 |
|
|
|
3.86 |
|
|
|
- |
|
| SARs expected to vest in the future as of March 31, 2023 |
|
|
688,864 |
|
|
|
2.01 |
|
|
|
4.02 |
|
|
|
- |
|
| SARs exercisable at March 31, 2023 |
|
|
302,767 |
|
|
|
2.75 |
|
|
|
3.49 |
|
|
|
- |
|
| SARs vested, exercisable, and SARs expected to vest at March 31, 2023 |
|
|
991,631 |
|
|
|
2.23 |
|
|
|
3.86 |
|
|
|
- |
|
|